Source: International Congress 2016 – Translational research in respiratory infections
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Birgitt Gutbier (Berlin, Germany), Birgitt Gutbier, Xiaohui Jiang, Carolin Ehrler, Tim J. Mitchell, Norbert Weissmann, Paul Van Slyke, Dan J. Dumont, Norbert Suttorp, Martin Witzenrath. Vasculotide reduced pulmonary hyperpermeability in pneumococcal pneumonia. Eur Respir J 2016; 48: Suppl. 60, 4990

Member's Comments

No comment yet.

Related content which might interest you: Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis Source: International Congress 2014 – Critical illness and therapeutic interventions Year: 2014 Arterial oxygen content could reflect acute organ damage in community-acquired pneumonia Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP) Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Acute respiratory failure and severe sepsis may identify different clinical phenotypes in community-acquired pneumonia Source: Annual Congress 2013 –Interesting research questions Year: 2013 Pulmonary fibrosis in mice increases susceptibility to pneumococcal pneumonia and bacteremia Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 Aerobic exercise inhibits pseudomonas aeruginosa-induced acute lung injury in elderly mice Source: International Congress 2014 – Immunology of respiratory infections Year: 2014 CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Viral infections Year: 2013 Tiotropium attenuates pulmonary inflammation in a novel mouse smoke RSV re-infection model Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Characteristics of pnemococcal community-acquired pneumonia presenting with respiratory failure Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Outcome of high-flow nasal cannula for acute hypoxemic respiratory failure due to pneumocystis pneumonia Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality Year: 2016 Obstructive pulmonary disease with acute respiratory failure Source: ISSN=1025-448x, ISBN=1-904097-17-0, page=11 Year: 2001 Predictors of failure of noninvasive ventilation in acute cardiogenic pulmonary edema Source: Annual Congress 2013 –NIV in the acute setting: growing experience and novel applications Year: 2013 Markers of sudden cardiac arrest in patients with severe respiratory infections Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Impact of bacterial infections on airway diseases Source: Eur Respir Rev 2005; 14: 62-68 Year: 2005